- Home
- NDSN vs QGEN Comparison
NDSN vs QGEN Comparison
Compare NDSN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDSN
- QGEN
- Stock Information
- Founded
- NDSN 1935
- QGEN 1986
- Country
- NDSN United States
- QGEN Netherlands
- Employees
- NDSN N/A
- QGEN N/A
- Industry
- NDSN Industrial Machinery/Components
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NDSN Industrials
- QGEN Health Care
- Exchange
- NDSN Nasdaq
- QGEN Nasdaq
- Market Cap
- NDSN 10.1B
- QGEN 10.3B
- IPO Year
- NDSN N/A
- QGEN 1996
- Fundamental
- Price
- NDSN $227.17
- QGEN $49.74
- Analyst Decision
- NDSN Strong Buy
- QGEN Buy
- Analyst Count
- NDSN 6
- QGEN 8
- Target Price
- NDSN $262.83
- QGEN $51.01
- AVG Volume (30 Days)
- NDSN 399.3K
- QGEN 1.3M
- Earning Date
- NDSN 08-20-2025
- QGEN 08-05-2025
- Dividend Yield
- NDSN 1.42%
- QGEN 3.07%
- EPS Growth
- NDSN N/A
- QGEN 405.07
- EPS
- NDSN 7.95
- QGEN 1.69
- Revenue
- NDSN $2,784,349,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- NDSN $5.77
- QGEN $6.41
- Revenue Next Year
- NDSN $4.99
- QGEN $5.70
- P/E Ratio
- NDSN $28.57
- QGEN $29.38
- Revenue Growth
- NDSN 4.49
- QGEN 5.15
- 52 Week Low
- NDSN $165.03
- QGEN $37.63
- 52 Week High
- NDSN $266.86
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- NDSN 62.43
- QGEN 55.69
- Support Level
- NDSN $213.23
- QGEN $48.62
- Resistance Level
- NDSN $235.71
- QGEN $49.50
- Average True Range (ATR)
- NDSN 5.11
- QGEN 0.72
- MACD
- NDSN 1.02
- QGEN -0.03
- Stochastic Oscillator
- NDSN 67.24
- QGEN 82.19
About NDSN Nordson Corporation
Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.7 billion in revenue in its fiscal 2024.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).